Filter By Industry
Filter By Tag

Newsroom

CR Life Sc Insights Press releases

1 - 2 of 2 Press Releases

Apr 21, 2018
Anti-migraine medical devices will grab 5% market share in the United Kingdom and  3% in Germany in revenues in 2022 Whilst medical devices will gain two percentage points versus therapeutic drugs from 2018 to 2022 in terms of market share revenues..

Apr 10, 2018
Unravelling many opportunities and some threats in the market to treat migraine.


CR Life Sc Insights RSS Feed